Poland – Pharmaceutical products – ZP/CZD/093/26 SUPPLY OF MEDICINAL PRODUCTS – 16 packages
The subject of the contract is the supply of medicinal products – 16 packages under the terms set out in the draft contractual provisions, in quantities resulting from current needs and within the time limits resulting from the concluded contract. The contracting authority allo
Opportunity description
The subject of the contract is the supply of medicinal products – 16 packages under the terms set out in the draft contractual provisions, in quantities resulting from current needs and within the time limits resulting from the concluded contract. The contracting authority allows the submission of partial tenders for packages, in which case the contractor may submit a tender for a selected package or all packages listed in Appendix No. 1 to the SWZ (OPZ). The subject of the contract is the Supply of Amphotericinum B in liposomes, vial + filter. Detailed information on the scope is contained in - Appendices Nos. 1 and 5 to the SWZ. The subject of the contract is: Supply of Antithrombinum 1000 IU. Indications for use in congenital and acquired antithrombin deficiency described in the SmPC, without contraindications in children from 6 years of age. Detailed information on the scope is contained in - Appendices Nos. 1 and 5 to the SWZ. The subject of the contract is: Supply of Antithrombinum 500 IU. Indications for use in congenital and acquired antithrombin deficiency described in the SmPC, without contraindications in children from 6 years of age. Detailed information on the scope is contained in - Appendices Nos. 1 and 5 to the SWZ. The subject of the contract is the supply of: Human plasma proteins, solution for infusion, blood group depending on the contracting authority's needs, bag. Detailed information on the scope is contained in - Appendices Nos. 1 and 5 to the SWZ. The subject of the contract is the supply of: Ibuprofenum 4 mg/ml, solution for infusion. The contracting authority requires that the medicinal product offered be suitable for use in adolescents and children weighing ≥ 20 kg and aged 6 years and older. Detailed information on the scope is contained in - Appendices Nos. 1 and 5 to the SWZ. The subject of the contract is the supply of Indocyanine green. Detailed information on the scope is contained in - Appendices Nos. 1 and 5 to the SWZ. The subject of the contract is the supply of Micafunginum 100 mg, powder for preparation of a solution for infusion, with stability of the concentrate prepared in the vial. Without contraindications for use in newborns. Detailed information on the scope is contained in - Appendices Nos. 1 and 5 to the SWZ. The subject of the contract is the supply of Micafunginum 50 mg, powder for preparation of a solution for infusion, with stability of the concentrate prepared in the vial. Without contraindications for use in newborns. Detailed information on the scope is contained in - Appendices Nos. 1 and 5 to the SWZ. The subject of the contract is the supply of Somatostatinum 3 mg, vial + solvent. Detailed information on the scope is contained in - Appendices Nos. 1 and 5 to the SWZ. The subject of the contract is the supply of products made from equine collagen coated with fibrin glue in which fibrinogen and thrombin are of human origin in solid form, various sizes. Detailed information on the scope is contained in - Appendices Nos. 1 and 5 to the SWZ. The subject of the contract is the supply of Ketaminum 50 mg. Detailed information on the scope is contained in - Appendices Nos. 1 and 5 to the SWZ. The subject of the contract is the supply of Midazolamum inj. 5 mg. Detailed information on the scope is contained in - Appendices Nos. 1 and 5 to the SWZ. The subject of the contract is the supply of Midazolamum - solution for oral use. Detailed information on the scope is contained in - Appendices Nos. 1 and 5 to the SWZ. The subject of the contract is the supply of medicinal products: 1. Clobazamum 2. Clonazepamum 0.5 mg 3. Clonazepamum 1mg 4. Clonazepamum 2 mg 5. Diazepamum 2 mg 6. Diazepamum 5 mg 7. Dikalii clorazepas 5 mg 8. Dikalii clorazepas 20 mg 9. Fentanylum 10. Luminalum 100 mg 11. Luminalum 15 mg 12. Methadonum hydrochloricum syrup 13. Methylphenidati hydrochloridum tablets 14. Midazolamum 15. Nalbuphinum 17. Remifentanilum 18. Risperidonum. Detailed information on the scope is contained in - Appendices Nos. 1 and 5 to the SWZ. The subject of the contract is the supply of medicinal products: 1. Diazepamum 2. Diazepamum 3. Diazepamum 4. Fentanylum 5. Lorazepamum 6. Lorazepamum 7. Lorazepamum 8. Morphinum sulfuricum 9. Risperidonum. Detailed information on the scope is contained in - Appendices Nos. 1 and 5 to the SWZ. The subject of the contract is the supply of Sufentanylum in various doses. Detailed information on the scope is contained in - Appendices Nos. 1 and 5 to the SWZ. Procedure: open. Estimated value: 5,253,272.02 PLN. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.